Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
52.3M
-
Number of holders
-
40
-
Total 13F shares, excl. options
-
13.8M
-
Shares change
-
-1.02M
-
Total reported value, excl. options
-
$17.6M
-
Value change
-
-$1.34M
-
Number of buys
-
9
-
Number of sells
-
-17
-
Price
-
$1.27
Significant Holders of ENZO BIOCHEM INC - Common Stock, par value $0.01 per share (ENZB) as of Q1 2024
49 filings reported holding ENZB - ENZO BIOCHEM INC - Common Stock, par value $0.01 per share as of Q1 2024.
ENZO BIOCHEM INC - Common Stock, par value $0.01 per share (ENZB) has 40 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.8M shares
of 52.3M outstanding shares and own 26.45% of the company stock.
Largest 10 shareholders include HARBERT FUND ADVISORS, INC. (5.18M shares), RENAISSANCE TECHNOLOGIES LLC (2.44M shares), VANGUARD GROUP INC (1.88M shares), TANG CAPITAL MANAGEMENT LLC (1.26M shares), BlackRock Inc. (954K shares), DIMENSIONAL FUND ADVISORS LP (656K shares), GEODE CAPITAL MANAGEMENT, LLC (338K shares), RBF Capital, LLC (250K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (227K shares), and STATE STREET CORP (154K shares).
This table shows the top 40 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.